CEO Michael Castagna Purchases $259,000 in Company Stock
MNKD is trading near its 52-week low of $2.522 (8.1% above the low).
Summary
MannKind's CEO, Michael Castagna, purchased $259,000 worth of common stock in an open-market transaction, demonstrating executive confidence following recent financial reports.
Key Events · Ownership and Investor Activity · MNKD
-
CEO Stock Purchase
Michael Castagna, CEO and Director, acquired 100,000 shares of common stock for a total of $259,000 at an average price of $2.59 per share on March 10, 2026.
-
Executive Confidence Signal
This open-market purchase by the top executive indicates strong belief in the company's value and future performance, especially following the recent Q4 and full-year 2025 earnings report on February 26, 2026.
Analysis · MNKD · Life Sciences
Michael Castagna, CEO and Director of MannKind Corporation, made a significant open-market purchase of company stock, investing $259,000. This transaction, occurring shortly after the company reported its Q4 and full-year 2025 financial results on February 26, 2026, signals strong confidence from the top executive in the company's future prospects and valuation, despite a reported decline in net income.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1996 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MNKD was trading at $2.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $839.6M. The 52-week trading range was $2.52 to $6.51. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.